✨ Medicine Distribution Consents




16 DECEMBER 2010 NEW ZEALAND GAZETTE, No. 173 4259

Product:
Protaphane
Active Ingredient:
Isophane insulin, human, pyr 100IU/mL
Dosage Form:
Suspension for injection
New Zealand Sponsor:
Novo Nordisk Pharmaceuticals Limited
Manufacturers:
Novo Nordisk A/S, Copenhagen, Denmark
Novo Nordisk A/S, Kalundborg, Denmark

Product:
Protaphane Flexpen
Active Ingredient:
Isophane insulin, human, pyr 100IU/mL
Dosage Form:
Suspension for injection
New Zealand Sponsor:
Novo Nordisk Pharmaceuticals Limited
Manufacturers:
Novo Nordisk A/S, Copenhagen, Denmark
Novo Nordisk A/S, Kalundborg, Denmark
Novo Nordisk Production SAS, Chartres Cedex, France
Novo Nordisk Producao Farmaceutica do Brasil Limitada, Montes Claros, Brazil

Product:
Protaphane Innolet
Active Ingredient:
Isophane insulin, human, pyr 100IU/mL
Dosage Form:
Suspension for injection
New Zealand Sponsor:
Novo Nordisk Pharmaceuticals Limited
Manufacturers:
Novo Nordisk A/S, Copenhagen, Denmark
Novo Nordisk A/S, Kalundborg, Denmark
Novo Nordisk Producao Farmaceutica do Brasil Limitada, Montes Claros, Brazil

Product:
Protaphane Penfill
Active Ingredient:
Isophane insulin, human, pyr 100IU/mL
Dosage Form:
Suspension for injection
New Zealand Sponsor:
Novo Nordisk Pharmaceuticals Limited
Manufacturers:
Novo Nordisk A/S, Copenhagen, Denmark
Novo Nordisk A/S, Hillerod, Denmark
Novo Nordisk A/S, Kalundborg, Denmark
Novo Nordisk Production SAS, Chartres Cedex, France
Novo Nordisk Pharmaceutical Industries Inc, Clayton, United States of America
Novo Nordisk Producao Farmaceutica do Brasil Limitada, Montes Claros, Brazil

Dated this 14th day of December 2010.

JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go9608

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Amlodipine Pfizer
Active Ingredient:
Amlodipine besilate 6.9348mg equivalent to amlodipine 5mg
Dosage Form:
Tablet
New Zealand Sponsor:
Pfizer New Zealand Limited
Manufacturer:
Aurobindo Pharma Limited, Hyderabad, India

Product:
Amlodipine Pfizer
Active Ingredient:
Amlodipine besilate 13.8696mg equivalent to amlodipine 10mg
Dosage Form:
Tablet
New Zealand Sponsor:
Pfizer New Zealand Limited
Manufacturer:
Aurobindo Pharma Limited, Hyderabad, India

Product:
Auro-Amlodipine 10
Active Ingredient:
Amlodipine besilate 13.8696mg equivalent to amlodipine 10mg
Dosage Form:
Tablet
New Zealand Sponsor:
Pfizer New Zealand Limited
Manufacturer:
Aurobindo Pharma Limited, Hyderabad, India

Product:
Auro-Amlodipine 5
Active Ingredient:
Amlodipine besilate 6.9348mg equivalent to amlodipine 5mg
Dosage Form:
Tablet
New Zealand Sponsor:
Pfizer New Zealand Limited
Manufacturer:
Aurobindo Pharma Limited, Hyderabad, India



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2010, No 173





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
14 December 2010
Medicines, Distribution, Consent, Medicines Act 1981, Insulin, Novo Nordisk, Protaphane
  • JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
Medicines, Distribution, Consent, Medicines Act 1981, Amlodipine, Pfizer, Aurobindo